Case Study: Acerand Therapeutics centralizes drug discovery data and protects IP with CDD Vault

Acerand Therapeutics boosts CRO collaboration with CDD Vault in just 1 hour of training

Acerand Therapeutics, an early-stage biotech company, needed a centralized informatics platform to manage its small molecule and assay data across two global sites and multiple CROs. Their challenge was to enable secure collaboration and protect intellectual property without the internal IT support typically found at large pharmaceutical companies. They chose to implement CDD Vault from Collaborative Drug Discovery to meet these needs.

The solution from CDD Vault provided a secure, shared environment with project-level controls and structure masking, allowing Acerand to separate data for internal teams and external partners. This enabled direct data loading from CROs and supported remote work. The results included streamlined collaboration, robust IP protection, and enhanced data visualization, all achieved with minimal training required for users. CDD Vault proved to be an ideal fit for the company's specific needs as an early-stage drug discovery startup.

Acerand Therapeutics